Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar 25:2013:413146.
doi: 10.1155/2013/413146. Print 2013.

Does combination therapy with desmopressin and tolterodine improve the treatment outcomes of patients with monosymptomatic nocturnal enuresis? A randomized clinical controlled trial

Fahimeh Kazemi Rashed  1 , Davoud Nourizade, Sakineh Hajebrahimi, Kamaleddin Hasanzade, Abdolreza Otoofat
Affiliations

Does combination therapy with desmopressin and tolterodine improve the treatment outcomes of patients with monosymptomatic nocturnal enuresis? A randomized clinical controlled trial

Fahimeh Kazemi Rashed et al. ISRN Urol. .

Abstract

Several therapeutic options have been described for children with nocturnal enuresis, but still their efficacy and outcomes are controversial. This study compares the combined Desmopressin and Tolterodine efficacy versus Desmopressin alone efficacy in the treatment of nocturnal enuresis. One hundred children 5-16 years old with nocturnal enuresis were enrolled in a randomized trial study and were assigned to two equal groups. In a double-blind manner, we used 2 mg of Tolterodine tablet plus 20 μ g of nasal Desmopressin in group A and 20 μ g of nasal Desmopressin plus placebo in group B. The two groups were matched for age and sex (P = 0.547, P = 0.414). The mean number of the wet nights was reduced in both groups (P < 0.001, P < 0.001). Upon ICCS scoring in the Tolterodine + Desmopressin group, 27 (54%) had full response, 17 (34%) had partial response, and 5 (10%) had an unsuccessful outcome. In the Desmopressin + placebo group, 17 (34%) had full response, 23 (46%) had partial response, and 10 (20%) had an unsuccessful outcome. The response in the Tolterodine + Desmopressin group was significantly higher (P = 0.049). Regarding the results, combined Tolterodine plus Desmopressin is slightly more effective than monotherapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Response to the treatment upon CICCS scoring.
See this image and copyright information in PMC

References

    1. Foxman B, Valdez RB, Brook RH. Childhood enuresis: Prevalence, perceived impact, and prescribed treatments. Pediatrics. 1986;77(4):482–487. - PubMed
    1. Nevéus T, von Gontard A, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: report from the standardisation committee of the international children’s continence society. Journal of Urology. 2006;176(1):314–324. - PubMed
    1. Terho P. Desmopressin in nocturnal enuresis. Journal of Urology. 1991;145(4):818–820. - PubMed
    1. Yeung CK, Chiu HN, Sit FKY. Bladder dysfunction in children with refractory monosymptomatic primary nocturnal enuresis. Journal of Urology. 1999;162(3):1049–1055. - PubMed
    1. Vande Walle J, Vande Walle C, Van Sintjan P, et al. Nocturnal polyuria is related to 24-hour diuresis and osmotic excretion in an enuresis population referred to a tertiary center. Journal of Urology. 2007;178(6):2630–2634. - PubMed

LinkOut - more resources